Related Experiment Videos
Protein expression in human non-small cell lung cancer: a systematic database.
Rena Isabel Bührens1, Julius Titus Amelung, Marc André Reymond
1Department of General, Gastrointestinal and Thoracic Surgery, Evangelic Hospital Bielefeld, DE-33617 Bielefeld, Germany.
Summary
This study integrates proteomics data from non-small cell lung cancer (NSCLC) studies. Few proteins overlap between squamous cell carcinoma (SCC) and adenocarcinoma (AC), but three key proteins may play significant roles in lung cancer.
Area of Science:
- Proteomics
- Oncology
- Biochemistry
Background:
- Non-small cell lung cancer (NSCLC) is a major cause of cancer-related mortality.
- Understanding the molecular differences between NSCLC subtypes, such as squamous cell carcinoma (SCC) and adenocarcinoma (AC), is crucial for targeted therapies.
- Proteomics offers a powerful approach to identify disease biomarkers and therapeutic targets.
Purpose of the Study:
- To create a comprehensive database of proteomics findings in human NSCLC.
- To identify differentially expressed proteins in SCC and AC subtypes of NSCLC.
- To pinpoint potential protein biomarkers and therapeutic targets common to both SCC and AC.
Main Methods:
- Systematic review and integration of published proteomics studies on NSCLC.
- Analysis of data from 12 studies encompassing human cancer tissues, sera, and cell lines.
- Utilized techniques including 2D-PAGE, DIGE, and SERPA for protein analysis.
Main Results:
- A total of 261 differentially expressed proteins were identified across 306 NSCLC patients.
- A significant portion (74%) of identified proteins were unique to a single study, indicating low overlap.
- Only a small number of proteins were consistently reported across multiple studies.
Conclusions:
- Protein expression profiles show limited overlap between SCC and AC subtypes of NSCLC.
- Triosephosphate isomerase, protein disulfide isomerase, and phosphoglycerate mutase (phosphoglycerate kinase 1) were found to be upregulated in both SCC and AC.
- These consistently upregulated proteins represent potential key players and therapeutic targets in human lung cancer.